Content about Final

Behind every prescription that lands at the pharmacy counter is a series of events that influence the prescriber’s decision. Powered by data from SDI Health, Drug Store News goes inside the examination room in this exclusive report, providing an in-depth look at the critical factors that shape pharmaceutical sales trends and shift market share from one drug to another in 10 key market segments.

Click below to download the complete PDF of the 2011 Annual Prescriber Report.

Happy days are here again! Consumer confidence rebounded 1.6 points in April from a dip in March, according to the Consumer Confidence Index, despite the fact that high-gas-price stories are dominating the airwaves. That suggests consumers may be willing to try new things again — in other words, to buy something new — and that is excellent news for niche manufacturers. In this annual report, DSN calculates the value of niche brands.

Click below to download the PDF of the Top 150 Annual Niche Brands Report.

In November 2010, The Drug Store News Group hosted in New York an exclusive round-table discussion among leading executives from a vast array of retailers and a handful of key vendors. Moderated by DSN editor-in-chief Rob Eder, the panel tackled a wide range of issues, from the role of private label to improving store execution, inventory optimization and more. In part two, featured here, the panel tackles beauty care.

Click below to download the PDF of the 12th Annual Industry Issues Summit - Part 2.

In November 2010, The Drug Store News Group hosted in New York an exclusive round-table discussion among leading executives from a vast array of retailers and a handful of key vendors. Moderated by DSN publisher Wayne Bennett, the panel tackled a wide range of issues, from the role of private label to improving store execution, inventory optimization and more. In part one, featured here, the panel tackles health and wellness. Click below to download the PDF of the 12th Annual Industry Isssues Summit - Part 1.

Talk about a bold retail vision. Walgreens president and CEO Greg Wasson said the nation’s top pharmacy retailer wants nothing less than to “own well.” He’s serious. Owning “well” — or, put another way, becoming the nation’s top retail resource for pharmacy and health-and-wellness services and products — is the kind of declaration few retail pharmacy executives would dare utter. But Wasson isn’t running just any drug store chain.

PHOENIX — Ernst & Young has named Avella Specialty Pharmacy founder and CEO John Musil as a finalist for a regional award.

Avella said Musil had been shortlisted for the Entrepreneur of the Year 2013 Award in the Mountain Desert region, which includes Colorado, Arizona and New Mexico. Avella is headquartered in Phoenix.

NEW YORK — Coty Inc. has reached an agreement to acquire StarAsia, a distributor of beauty products in the markets of Southeast Asia — Cambodia, Hong Kong, Indonesia, Malaysia, Singapore, Taiwan and Vietnam — from Isibane Pte. Ltd.

Financial terms of the deal, which is expected to close in the summer, were not disclosed.

The offices of Drug Store News will be closed Friday, May 24, and Monday, May 27, in observance of Memorial Day. We wish you a safe and happy holiday.

WASHINGTON — Aftershocks from last year's nationwide outbreak of fungal meningitis linked to a Massachusetts-based compounding pharmacy continued to be felt in a House subcommittee meeting Thursday.

The House Energy and Commerce Committee Subcommittee on Health convened a hearing to examine the state of pharmacy compounding in the United States and the current regulatory environment under which it operates.

LOS ANGELES — Kathy Ireland, CEO and chief designer of Kathy Ireland Worldwide and women’s health advocate, is collaborating with board-certified surgeon Dr. David Scharp in bringing to the beauty market a stem cell-derived product brand called Stemáge.

They note that the unique aspect of the natural skin rejuvenation system is that it targets visible signs of aging through the proprietary use of human Mesenchymal stem cell derivatives, not stem cells but rather active ingredients or derivatives of which stem cells are comprised.

WASHINGTON — More than half of all healthcare providers who are eligible have received Medicare and Medicaid incentive payments for electronic health records, the Department of Health and Human Services said.

HHS secretary Kathleen Sebelius said the department had exceeded its goal for 50% of doctor offices and 80% of hospitals to have EHRs by the end of the year. By contrast, the percentage of physicians using EHRs in 2008 was 17%. The American Recovery and Reinvestment Act of 2009 contained incentive programs for adoption of EHRs that went into effect in 2011.